Your session is about to expire
← Back to Search
Deep Sequencing Test for Intraocular Infections (OPTICS Trial)
OPTICS Trial Summary
This trial is designed to compare the effectiveness of a new deep sequencing test for intraocular infections versus the current standard of care test. Patients who receive the new test will be compared to those who do not to see if there are improved outcomes.
OPTICS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOPTICS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OPTICS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have an eye infection affecting the front, middle, back, or all parts of my eye.I am unable to give consent by myself.You have an issue that affects either one or both sides of your body.I have an eye inflammation that affects the front, middle, or back part of my eye.I am under 18 years old.I am suspected to have an eye infection after surgery.I am 18 years old or older.I am suspected to have an eye infection after surgery.
- Group 1: MDS
- Group 2: Standard of Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still openings to participate in this experiment?
"Affirmative. According to the clinicaltrials.gov database, this experiment is currently seeking participants and was originally posted on June 6th 2022 with updates occuring as recently as July 5th 2022. The study requires 100 people from a single medical facility for enrolment purposes."
What does this clinical experiment hope to demonstrate?
"This medical trial, evaluated over 4 weeks after randomisation, aims to evaluate clinical improvement. Secondary objectives include measuring infection status with latent class analysis and traditional tests; calculating provider quality of care through the World Health Organization Quality of Life Abbreviated Questionnaire; as well as capturing a provider's certainty on whether or not a patient has an infection (on a continuous scale from 0-100%)."
What is the current capacity to enroll participants for this medical experiment?
"Affirmative, the information hosted on clinicaltrials.gov verifies that this medical trial is currently recruiting. Its first posting was June 6th 2022 and its most recent edit occurred July 5th 2022; 100 patients are needed from a single site."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger